Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy.
ClinicalTrials.gov study NCT03704480. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy
ClinicalTrials.gov study NCT01904253. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Study of Pembrolizumab (MK-3475) Versus Platinum-Based Chemotherapy for Participants With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (MK-3475-042
ClinicalTrials.gov study NCT03850444. IPD Sharing: YES. Countries: 0. Publications: 1.
Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT01590160. IPD Sharing: Not stated. Countries: 1. Publications: 1.
3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT00081276. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Niraparib and Bevacizumab Maintenance Therapy in Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor
ClinicalTrials.gov study NCT04734665. IPD Sharing: NO. Countries: 1. Publications: 1.
Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy
ClinicalTrials.gov study NCT00006028. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Trial Of Cisplatin And KML-001 in Platinum Responsive Malignancies
ClinicalTrials.gov study NCT01110226. IPD Sharing: NO. Countries: 1. Publications: 1.
Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer
ClinicalTrials.gov study NCT05080556. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT05979298. IPD Sharing: NO. Countries: 1. Publications: 2.
Efficacy and Safety of Sintilimab Plus Bevacizumab in Metastatic Nasopharyngeal Carcinoma After Failure of Platinum-based Chemotherapy: An Open-label Phase II Study
ClinicalTrials.gov study NCT04872582. IPD Sharing: YES. Countries: 1. Publications: 1.
Toripalimab and Anlotinib Combination Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma After Failure of at Least One Line of Platinum-Based Chemotherapy (TORAL)
ClinicalTrials.gov study NCT04996758. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
ClinicalTrials.gov study NCT00068289. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Anlotinib Plus Platinum-etoposide in First-line of Extensive-stage Small-cell Lung Cancer
ClinicalTrials.gov study NCT04675697. IPD Sharing: YES. Countries: 1. Publications: 1.
Neoadjuvant Toripalimab Plus Platinum-based Doublet for Stage III Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04304248. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Camrelizumab Combined With Apatinib in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT04547088. IPD Sharing: Not stated. Countries: 1. Publications: 9.
Trial on NIraparib-TSR-042 (Dostarlimab) vs Physician's Choice CHEmotherapy in Recurrent, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment
ClinicalTrials.gov study NCT04679064. IPD Sharing: NO. Countries: 1. Publications: 1.
Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT03949283. IPD Sharing: NO. Countries: 1. Publications: 2.
Bare Platinum Coils Versus Second-generation Hydrocoils
ClinicalTrials.gov study NCT04988503. IPD Sharing: NO. Countries: 1. Publications: 0.
Apatinib Combined With PLD vs PLD for Platinum-resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT04348032. IPD Sharing: NO. Countries: 1. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.